Genetic animal models of anxiety

[1]  S. File,et al.  Animal Tests of Anxiety , 2004, Current protocols in neuroscience.

[2]  R. Landgraf.  Animal models of anxiety. , 2003, Stress.

[3]  M. Cavallini,et al.  No Association Between Obsessive-Compulsive Disorder and the 5-HT1Dβ Receptor Gene , 2002 .

[4]  R. Landgraf,et al.  High vs Low Anxiety-Related Behavior Rats: An Animal Model of Extremes in Trait Anxiety , 2002, Behavior genetics.

[5]  T. Hijzen,et al.  Autonomic Changes Associated with Enhanced Anxiety in 5-HT1A Receptor Knockout Mice , 2002, Neuropsychopharmacology.

[6]  D. Overstreet.  Behavioral Characteristics of Rat Lines Selected for Differential Hypothermic Responses to Cholinergic or Serotonergic Agonists , 2002, Behavior genetics.

[7]  D. Blizard,et al.  The Maudsley Reactive and Nonreactive Strains: A New Perspective , 2002, Behavior genetics.

[8]  G. Homanics,et al.  GABAA receptor alpha-1 subunit deletion alters receptor subtype assembly, pharmacological and behavioral responses to benzodiazepines and zolpidem , 2002, Neuropharmacology.

[9]  A. Bradley,et al.  Urocortin-Deficient Mice Display Normal Stress-Induced Anxiety Behavior and Autonomic Control but an Impaired Acoustic Startle Response , 2002, Molecular and Cellular Biology.

[10]  M. Scheinin,et al.  Behavioral and neurochemical characterization of α2A-adrenergic receptor knockout mice , 2002, Neuroscience.

[11]  G. Koob,et al.  Urocortin-deficient mice show hearing impairment and increased anxiety-like behavior , 2002, Nature Genetics.

[12]  F. Holsboer,et al.  Effects of transgenic overproduction of CRH on anxiety‐like behaviour , 2002, The European journal of neuroscience.

[13]  M. Cavallini,et al.  Exploratory factor analysis of obsessive-compulsive patients and association with 5-HTTLPR polymorphism. , 2002, American journal of medical genetics.

[14]  G. Dawson,et al.  A quantitative trait locus influencing anxiety in the laboratory rat. , 2002, Genome research.

[15]  René Hen,et al.  Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult , 2002, Nature.

[16]  Simon Easteal,et al.  Association of polymorphisms of the estrogen receptor gene with anxiety-related traits in children and adolescents: a longitudinal study. , 2002, American journal of medical genetics.

[17]  S. Claes,et al.  Gene-based SNP genetic association study of the corticotropin-releasing hormone receptor-2 (CRHR2) in major depression. , 2002, American journal of medical genetics.

[18]  Robert A Zucker,et al.  Serotonin transporter promoter polymorphism, peripheral indexes of serotonin function, and personality measures in families with alcoholism. , 2002, American journal of medical genetics.

[19]  L. Abramova,et al.  5HTR2A gene polymorphism and personality traits in patients with major psychoses , 2002, European Psychiatry.

[20]  M. Leboyer,et al.  Association between the COMT locus and obsessive-compulsive disorder in females but not males. , 2002, American journal of medical genetics.

[21]  G. Koob,et al.  Mice Deficient for Both Corticotropin-Releasing Factor Receptor 1 (CRFR1) and CRFR2 Have an Impaired Stress Response and Display Sexually Dichotomous Anxiety-Like Behavior , 2002, The Journal of Neuroscience.

[22]  G. Dawson,et al.  Learned fear, emotional reactivity and fear of heights: a factor analytic map from a large F2 intercross of Roman rat strains , 2002, Brain Research Bulletin.

[23]  Qian Li,et al.  Genetic perspectives on the serotonin transporter , 2001, Brain Research Bulletin.

[24]  R. Hen,et al.  Serotonin(1A) receptors in mood disorders: a combined genetic and genomic approach. , 2001, Behavioural pharmacology.

[25]  M C Neale,et al.  A review and meta-analysis of the genetic epidemiology of anxiety disorders. , 2001, The American journal of psychiatry.

[26]  I. Liberzon,et al.  Summary of a National Institute of Mental Health workshop: developing animal models of anxiety disorders , 2001, Psychopharmacology.

[27]  A. V. Anagnostopoulos,et al.  Transgenic and knockout databases Behavioral profiles of mouse mutants , 2001, Physiology & Behavior.

[28]  P. Gass,et al.  Mice with targeted mutations of glucocorticoid and mineralocorticoid receptors: Models for depression and anxiety? , 2001, Physiology & Behavior.

[29]  J. Flint,et al.  Quantitative trait locus mapping in laboratory mice derived from a replicated selection experiment for open-field activity. , 2001, Genetics.

[30]  E. Hattori,et al.  Identification of a compound short tandem repeat stretch in the 5′-upstream region of the cholecystokinin gene, and its association with panic disorder but not with schizophrenia , 2001, Molecular Psychiatry.

[31]  K. Kendler,et al.  A Population-Based Twin Study of Generalized Anxiety Disorder in Men and Women , 2001, The Journal of nervous and mental disease.

[32]  M. P. McDonald,et al.  The α2A-Adrenergic Receptor Plays a Protective Role in Mouse Behavioral Models of Depression and Anxiety , 2001, The Journal of Neuroscience.

[33]  Jonathan Flint,et al.  QTL analysis identifies multiple behavioral dimensions in ethological tests of anxiety in laboratory mice , 2001, Current Biology.

[34]  G. Dawson,et al.  Loss of the Major GABAA Receptor Subtype in the Brain Is Not Lethal in Mice , 2001, The Journal of Neuroscience.

[35]  A. Holmes.  Targeted gene mutation approaches to the study of anxiety-like behavior in mice , 2001, Neuroscience & Biobehavioral Reviews.

[36]  A. Leslie Morrow,et al.  GABAA Receptor α1 Subunit Deletion Prevents Developmental Changes of Inhibitory Synaptic Currents in Cerebellar Neurons , 2001, The Journal of Neuroscience.

[37]  P. M. Wall,et al.  Methodological and conceptual issues in the use of the elevated plus-maze as a psychological measurement instrument of animal anxiety-like behavior , 2001, Neuroscience & Biobehavioral Reviews.

[38]  N. Laird,et al.  Genetic association analysis of behavioral inhibition using candidate loci from mouse models. , 2001, American journal of medical genetics.

[39]  U. Rudolph,et al.  GABA(A) receptor subtypes: dissecting their pharmacological functions. , 2001, Trends in pharmacological sciences.

[40]  G. Dawson,et al.  Lack of consistent behavioural effects of Maudsley reactive and non-reactive rats in a number of animal tests of anxiety and activity , 2001, Psychopharmacology.

[41]  R. Williams,et al.  Anxiety-related behaviors in the elevated zero-maze are affected by genetic factors and retinal degeneration. , 2001, Behavioral neuroscience.

[42]  R. Landgraf,et al.  Dimensions of emotionality in a rat model of innate anxiety. , 2001, Behavioral neuroscience.

[43]  J. Rosenbaum,et al.  Targeted genome screen of panic disorder and anxiety disorder proneness using homology to murine QTL regions. , 2001, American journal of medical genetics.

[44]  S. Korte.  Corticosteroids in relation to fear, anxiety and psychopathology , 2001, Neuroscience & Biobehavioral Reviews.

[45]  M. Mandelli,et al.  Molecular targets for the myorelaxant action of diazepam. , 2001, Molecular pharmacology.

[46]  D. Charney,et al.  Neurobiology of generalized anxiety disorder. , 2001, The Psychiatric clinics of North America.

[47]  D. Pickar,et al.  Pharmacogenomics of psychiatric disorders. , 2001, Trends in pharmacological sciences.

[48]  Dennis L. Murphy,et al.  Excessive Activation of Serotonin (5-HT) 1B Receptors Disrupts the Formation of Sensory Maps in Monoamine Oxidase A and 5-HT Transporter Knock-Out Mice , 2001, The Journal of Neuroscience.

[49]  R. Wilson,et al.  Genomewide survey of panic disorder. , 2001, American journal of medical genetics.

[50]  F. Holsboer,et al.  The anxiolytic effect of the CRH1 receptor antagonist R121919 depends on innate emotionality in rats , 2001, The European journal of neuroscience.

[51]  N. Kalin,et al.  Corticotropin-releasing hormone and animal models of anxiety: gene–environment interactions , 2000, Biological Psychiatry.

[52]  R. Gainetdinov,et al.  Potentiated Opioid Analgesia in Norepinephrine Transporter Knock-Out Mice , 2000, The Journal of Neuroscience.

[53]  René Hen,et al.  Altered fear circuits in 5-HT1A receptor KO mice , 2000, Biological Psychiatry.

[54]  N. Dahmen,et al.  The HTR1B 861G>C receptor polymorphism among patients suffering from alcoholism, major depression, anxiety disorders and narcolepsy , 2000, Psychiatry Research.

[55]  R. Krueger.  Phenotypic, genetic, and nonshared environmental parallels in the structure of personality: a view from the multidimensional personality questionnaire. , 2000, Journal of personality and social psychology.

[56]  D. Nutt,et al.  The psychobiology of anxiolytic drugs. Part 1: Basic neurobiology. , 2000, Pharmacology & therapeutics.

[57]  L. Tecott,et al.  Mouse models of serotonin receptor function: toward a genetic dissection of serotonin systems. , 2000, Pharmacology & therapeutics.

[58]  W. Sieghart.  Unraveling the function of GABAA receptor subtypes , 2000 .

[59]  T. Rülicke,et al.  Molecular and neuronal substrate for the selective attenuation of anxiety. , 2000, Science.

[60]  T. Steckler,et al.  Behavioural analysis of four mouse strains in an anxiety test battery , 2000, Behavioural Brain Research.

[61]  Steven P. Hamilton,et al.  Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22 , 2000, Biological Psychiatry.

[62]  Joseph H. Nadeau,et al.  The roads from phenotypic variation to gene discovery: mutagenesis versus QTLs , 2000, Nature Genetics.

[63]  T. Gasperoni,et al.  A genetic screen for novel behavioral mutations in mice , 2000, Molecular Psychiatry.

[64]  Maja Bucan,et al.  Behavior and mutagenesis screens: the importance of baseline analysis of inbred strains , 2000, Mammalian Genome.

[65]  R. Radcliffe,et al.  Behavioural changes produced by transgenic overexpression of γ2L and γ2S subunits of the GABAA receptor , 2000 .

[66]  A. Leon,et al.  Qualitative differences in manic symptoms during mixed versus pure mania. , 2000, Comprehensive psychiatry.

[67]  N. Toschi,et al.  Unconditioned anxiety and social behaviour in two rat lines selectively bred for high and low anxiety-related behaviour , 2000, Behavioural Brain Research.

[68]  J. Crabbe.  Use of genetic analyses to refine phenotypes related to alcohol tolerance and dependence. , 2000, Alcoholism, clinical and experimental research.

[69]  R. Mckernan,et al.  Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype , 2000, Nature Neuroscience.

[70]  Fei Xu,et al.  Mice lacking the norepinephrine transporter are supersensitive to psychostimulants , 2000, Nature Neuroscience.

[71]  C. Pavlides,et al.  Genetic Inactivation of the Serotonin1A Receptor in Mice Results in Downregulation of Major GABAA Receptor α Subunits, Reduction of GABAA Receptor Binding, and Benzodiazepine-Resistant Anxiety , 2000, The Journal of Neuroscience.

[72]  M. Bucan,et al.  Dissection of behavior and psychiatric disorders using the mouse as a model. , 2000, Human molecular genetics.

[73]  Susan E. Murray,et al.  Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2 , 2000, Nature Genetics.

[74]  M. Neale,et al.  A twin study of inattentive, aggressive, and anxious/depressed behaviors. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

[75]  O. Hermanson,et al.  Deletion of Crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2 , 2000, Nature Genetics.

[76]  V. Bolivar,et al.  List of transgenic and knockout mice: behavioral profiles , 2000, Mammalian Genome.

[77]  Paul E. Sawchenko,et al.  Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress , 2000, Nature Genetics.

[78]  D. Goldberg,et al.  Plato versus Aristotle: categorical and dimensional models for common mental disorders. , 2000, Comprehensive psychiatry.

[79]  C. Shapiro,et al.  Differentiating DSM-IV Anxiety and Depressive Disorders in the General Population: Comorbidity and Treatment Consequences , 2000, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[80]  T. Lipina,et al.  Features of the Genetically Defined Anxiety in Mice , 2000, Behavior genetics.

[81]  Joseph E LeDoux.  Emotion Circuits in the Brain , 2000 .

[82]  G. Perrault,et al.  Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice , 2000, Psychopharmacology.

[83]  G. Koob,et al.  Genetic Differences in Response to Novelty and Spatial Memory Using a Two-Trial Recognition Task in Mice , 2000, Neurobiology of Learning and Memory.

[84]  W. Maier,et al.  Generalized anxiety disorder (ICD‐10) in primary care from a cross‐cultural perspective: a valid diagnostic entity? , 2000, Acta psychiatrica Scandinavica.

[85]  A. Holmes,et al.  Corticosterone response to the plus-maze High correlation with risk assessment in rats and mice , 1999, Physiology & Behavior.

[86]  G. Koob,et al.  A role for corticotropin releasing factor and urocortin in behavioral responses to stressors , 1999, Brain Research.

[87]  R. Hen,et al.  Complications associated with genetic background effects in research using knockout mice , 1999, Psychopharmacology.

[88]  Jonathan Flint,et al.  High-resolution mapping of quantitative trait loci for emotionality in selected strains of mice , 1999, Mammalian Genome.

[89]  T. Eley,et al.  Exploring the covariation between anxiety and depression symptoms: a genetic analysis of the effects of age and sex. , 1999, Journal of child psychology and psychiatry, and allied disciplines.

[90]  A. Guidotti,et al.  Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[91]  J. Benson,et al.  Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes , 1999, Nature.

[92]  A. Świergiel,et al.  Behavioral responses to stress are intact in CRF-deficient mice , 1999, Brain Research.

[93]  S. Camper,et al.  Altered anxiety and weight gain in corticotropin-releasing hormone-binding protein-deficient mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[94]  P. Blier,et al.  Autoregulation of serotonin neurons: role in antidepressant drug action. , 1999, Pharmacological reviews.

[95]  M. Moisan,et al.  Identification of female-specific QTLs affecting an emotionality-related behavior in rats , 1999, Molecular Psychiatry.

[96]  O. Kretz,et al.  Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety , 1999, Nature Genetics.

[97]  W. Iacono,et al.  A twin study of state and trait anxiety in childhood and adolescence. , 1999, Journal of child psychology and psychiatry, and allied disciplines.

[98]  Bernhard Lüscher,et al.  Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues , 1999, Nature Neuroscience.

[99]  M. Catalano.  The challenges of psychopharmacogenetics. , 1999, American journal of human genetics.

[100]  I. Modai,et al.  Mouse strains differ in their sensitivity to alprazolam effect in the staircase test , 1999, Brain Research.

[101]  B. Guardiola-Lemaitre,et al.  Effects of Melatonin on Neophobic Responses in Different Strains of Mice , 1999, Pharmacology Biochemistry and Behavior.

[102]  R. Hen,et al.  Altered Emotional States in Knockout Mice Lacking 5-HT1A or 5-HT1B Receptors , 1999, Neuropsychopharmacology.

[103]  Trevor Sharp,et al.  A review of central 5-HT receptors and their function , 1999, Neuropharmacology.

[104]  G. Dawson,et al.  A STRATEGY TO HOME-IN ON POLYGENES INFLUENCING SUSCEPTIBILITY TO ANXIETY , 1999 .

[105]  R Hen,et al.  5-HT1B Receptor Knock-Out Mice Exhibit Increased Exploratory Activity and Enhanced Spatial Memory Performance in the Morris Water Maze , 1999, The Journal of Neuroscience.

[106]  C. Berridge,et al.  Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[107]  D. Bernstein,et al.  Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice. , 1999, Molecular pharmacology.

[108]  F. Holsboer,et al.  Enhanced conditioned approach responses in transgenic mice with impaired glucocorticoid receptor function , 1999, Behavioural Brain Research.

[109]  G. Koob,et al.  Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1 1 Published on the World Wide Web on 27 November 1998. 1 , 1999, Brain Research.

[110]  J. Crabbe.  Animal Models in Neurobehavioral Genetics: Methods for Estimating Genetic Correlation , 1999 .

[111]  J. Crabbe,et al.  Genetics of mouse behavior: interactions with laboratory environment. , 1999, Science.

[112]  M. Buhot,et al.  Anxiety, motor activation, and maternal-infant interactions in 5HT1B knockout mice. , 1999, Behavioral neuroscience.

[113]  M. Liebowitz,et al.  Update on the diagnosis and treatment of social anxiety disorder. , 1999, The Journal of clinical psychiatry.

[114]  J. Vincent,et al.  Investigation of cholecystokinin system genes in panic disorder , 1999, Molecular Psychiatry.

[115]  F. Holsboer,et al.  The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. , 1999, Journal of psychiatric research.

[116]  M. Fendt,et al.  The neuroanatomical and neurochemical basis of conditioned fear , 1999, Neuroscience & Biobehavioral Reviews.

[117]  Jurg Ott,et al.  Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder , 1999, Biological Psychiatry.

[118]  T. Eley,et al.  Using Genetic Analyses to Clarify the Distinction Between Depressive and Anxious Symptoms in Children , 1999, Journal of abnormal child psychology.

[119]  David W. Fulker,et al.  High-resolution mapping of quantitative trait loci in outbred mice , 1999, Nature Genetics.

[120]  S. Ueno,et al.  Polymorphisms of the human homologue of the Drosophila white gene are associated with mood and panic disorders , 1999, Molecular Psychiatry.

[121]  M. Geyer,et al.  Increased Exploratory Activity and Altered Response to LSD in Mice Lacking the 5-HT5A Receptor , 1999, Neuron.

[122]  S. Hodge,et al.  Lack of genetic linkage or association between a functional serotonin transporter polymorphism and panic disorder. , 1999, Psychiatric genetics.

[123]  S. Baekkeskov,et al.  Increased anxiety and altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[124]  Hiroshi Kunugi,et al.  Association between serotonin transporter gene polymorphism and anxiety-related traits , 1999, Biological Psychiatry.

[125]  L. Firestone,et al.  Normal electrophysiological and behavioral responses to ethanol in mice lacking the long splice variant of the γ2 subunit of the γ-aminobutyrate type A receptor , 1999, Neuropharmacology.

[126]  S. Hyman.  Brain neurocircuitry of anxiety and fear: implications for clinical research and practice. , 1998, Biological psychiatry.

[127]  M. Stein,et al.  Genetic linkage to the serotonin transporter protein and 5HT2A receptor genes excluded in generalized social phobia , 1998, Psychiatry Research.

[128]  J. Kauer,et al.  Perturbed dentate gyrus function in serotonin 5-HT2C receptor mutant mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[129]  L H Parsons,et al.  Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[130]  R. Kessler,et al.  Comorbidity as a fundamental feature of generalized anxiety disorders: results from the National Comorbidity Study (NCS) , 1998, Acta psychiatrica Scandinavica. Supplementum.

[131]  R Hen,et al.  Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[132]  M. Stryker,et al.  Local GABA circuit control of experience-dependent plasticity in developing visual cortex. , 1998, Science.

[133]  Florian Holsboer,et al.  Behavioral, Physiological, and Neuroendocrine Stress Responses and Differential Sensitivity to Diazepam in Two Wistar Rat Lines Selectively Bred for High- and Low-Anxiety–Related Behavior , 1998, Neuropsychopharmacology.

[134]  M Linnoila,et al.  Role of the serotonin transporter promoter polymorphism in anxiety-related traits. , 1998, Archives of general psychiatry.

[135]  M Toth,et al.  Increased anxiety of mice lacking the serotonin1A receptor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[136]  D. Pfaff,et al.  Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[137]  K. Ohara,et al.  No association between anxiety disorders and catechol-O-methyltransferase polymorphism , 1998, Psychiatry Research.

[138]  F. Holsboer,et al.  Behavioural profiles of two Wistar rat lines selectively bred for high or low anxiety-related behaviour , 1998, Behavioural Brain Research.

[139]  J Blangero,et al.  Anxiety proneness linked to epistatic loci in genome scan of human personality traits. , 1998, American journal of medical genetics.

[140]  F. Holsboer,et al.  Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1 , 1998, Nature Genetics.

[141]  G. Koob,et al.  Corticotropin Releasing Factor Receptor 1–Deficient Mice Display Decreased Anxiety, Impaired Stress Response, and Aberrant Neuroendocrine Development , 1998, Neuron.

[142]  E A Barnard,et al.  International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function. , 1998, Pharmacological reviews.

[143]  J. Flint,et al.  Genetic Selection and Differential Stress Responses: The Roman Lines/Strains of Rats , 1998, Annals of the New York Academy of Sciences.

[144]  R. Noyes,et al.  Possible association of a cholecystokinin promotor polymorphism (CCK-36CT) with panic disorder. , 1998, American journal of medical genetics.

[145]  T. Brown,et al.  Structural relationships among dimensions of the DSM-IV anxiety and mood disorders and dimensions of negative affect, positive affect, and autonomic arousal. , 1998, Journal of abnormal psychology.

[146]  D. Murphy,et al.  Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. , 1998, Molecular pharmacology.

[147]  S. Camper,et al.  Excess corticotropin releasing hormone-binding protein in the hypothalamic-pituitary-adrenal axis in transgenic mice. , 1998, The Journal of clinical investigation.

[148]  S E Hodge,et al.  Results of a genome-wide genetic screen for panic disorder. , 1998, American journal of medical genetics.

[149]  D. Hanahan,et al.  Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[150]  Fei Xu,et al.  Knockout of the Vesicular Monoamine Transporter 2 Gene Results in Neonatal Death and Supersensitivity to Cocaine and Amphetamine , 1997, Neuron.

[151]  S. Paul,et al.  Mapping quantitative trait loci for fear-like behaviors in mice. , 1997, Genomics.

[152]  A. Pickles,et al.  Genetics and developmental psychopathology: 1. Phenotypic assessment in the Virginia Twin Study of Adolescent Behavioral Development. , 1997, Journal of child psychology and psychiatry, and allied disciplines.

[153]  R. Rodgers.  Animal models of 'anxiety': where next? , 1997, Behavioural pharmacology.

[154]  M. Capecchi,et al.  Cleft palate in mice with a targeted mutation in the gamma-aminobutyric acid-producing enzyme glutamic acid decarboxylase 67. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[155]  Takeshi Kumazawa,et al.  Increased stress response and β–phenylethylamine in MAOB–deficient mice , 1997, Nature Genetics.

[156]  S. Kanba,et al.  Serotonin transporter gene regulatory region polymorphism and anxiety-related traits in the Japanese. , 1997, American journal of medical genetics.

[157]  H Ujike,et al.  VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[158]  K. Lesch,et al.  Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene , 1997, Molecular Psychiatry.

[159]  R. Noyes,et al.  Candidate gene study of eight GABAA receptor subunits in panic disorder. , 1997, The American journal of psychiatry.

[160]  N. Barden,et al.  Behavioral reactivity to aversive stimuli in a transgenic mouse model of impaired glucocorticoid (type II) receptor function: effects of diazepam and FG-7142 , 1997, Psychopharmacology.

[161]  T. Yagi,et al.  Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[162]  M. Scheinin,et al.  Gene targeting — homing in on α2-adrenoceptor-subtype function , 1997 .

[163]  M. Fanselow,et al.  Selective enhancement of emotional, but not motor, learning in monoamine oxidase A-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[164]  S. Heinrichs,et al.  Anti-sexual and anxiogenic behavioral consequences of corticotropin-releasing factor overexpression are centrally mediated , 1997, Psychoneuroendocrinology.

[165]  S. Paul,et al.  Mapping Quantitative Trait Loci for Open-Field Behavior in Mice , 1997, Behavior genetics.

[166]  J. Ott,et al.  Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[167]  F. Chaouloff,et al.  A multiple-test study of anxiety-related behaviours in six inbred rat strains , 1997, Behavioural Brain Research.

[168]  L. Firestone,et al.  Gene Knockout of the α6 Subunit of the γ-Aminobutyric Acid Type A Receptor: Lack of Effect on Responses to Ethanol, Pentobarbital, and General Anesthetics , 1997 .

[169]  J. Launay,et al.  Genetic factors regulate processes related to anxiety in mice , 1997, Brain Research.

[170]  A. Holmes,et al.  Animal models of anxiety: an ethological perspective. , 1997, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[171]  P. Somogyi,et al.  Ligand-Gated Ion Channel Subunit Partnerships: GABAAReceptor α6 Subunit Gene Inactivation Inhibits δ Subunit Expression , 1997, The Journal of Neuroscience.

[172]  D. Caldirola,et al.  Panic attacks: a twin study , 1997, Psychiatry Research.

[173]  M. Bihoreau,et al.  A major quantitative trait locus influences hyperactivity in the WKHA rat , 1996, Nature Genetics.

[174]  K. Lesch,et al.  Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region , 1996, Science.

[175]  J. Flint,et al.  Do animal models have a place in the genetic analysis of quantitative human behavioural traits? , 1996, Journal of Molecular Medicine.

[176]  F. Bloom,et al.  Learning impairment in transgenic mice with central overexpression of corticotropin-releasing factor , 1996, Neuroscience.

[177]  M. Åsberg,et al.  Origins of individual differences in anxiety proneness: a twin/adoption study of the anxiety‐related scales from the Karolinska Scales of Personality (KSP) , 1996, Acta psychiatrica Scandinavica.

[178]  L. Muglia,et al.  Production of Corticotropin‐releasing Hormone‐deficient Mice by Targeted Mutation in Embryonic Stem Cells , 1996, Annals of the New York Academy of Sciences.

[179]  K. Kendler.  Major Depression and Generalised Anxiety Disorder , 1996, British Journal of Psychiatry.

[180]  S. Heinrichs,et al.  CRH Overproduction in Transgenic Mice , 1996 .

[181]  S. Southwick,et al.  Noradrenergic mechanisms in stress and anxiety: I. preclinical studies , 1996, Synapse.

[182]  T. Lovenberg,et al.  Corticotrophin-releasing factor receptors: from molecular biology to drug design. , 1996, Trends in pharmacological sciences.

[183]  R. Mckernan,et al.  Which GABAA-receptor subtypes really occur in the brain? , 1996, Trends in Neurosciences.

[184]  M. Buhot,et al.  5-HT1B receptor knock out — behavioral consequences , 1995, Behavioural Brain Research.

[185]  David Lovejoy,et al.  Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor , 1995, Nature.

[186]  F. Holsboer,et al.  Long‐Term Antidepressant Treatment Reduces Behavioural Deficits in Transgenic Mice with Impaired Glucocorticoid Receptor Function , 1995, Journal of neuroendocrinology.

[187]  A. C. Collins,et al.  A simple genetic basis for a complex psychological trait in laboratory mice , 1995, Science.

[188]  K. Kendler,et al.  A twin study of generalized anxiety disorder and major depression , 1995, Psychological Medicine.

[189]  A. Aguzzi,et al.  Benzodiazepine-insensitive mice generated by targeted disruption of the gamma 2 subunit gene of gamma-aminobutyric acid type A receptors. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[190]  N. Castanon,et al.  Genetic analysis of the relationships between behavioral and neuroendocrine traits in roman high and low avoidance rat lines , 1995, Behavior genetics.

[191]  A. Aguzzi,et al.  Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. , 1995, Genes & development.

[192]  P. Gaspar,et al.  Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. , 1995, Science.

[193]  D. Wright,et al.  Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain , 1995, The Journal of comparative neurology.

[194]  F. Bloom,et al.  Psychopharmacology: The Fourth Generation of Progress , 1995 .

[195]  Takeshi Inoue,et al.  Regional changes in dopamine and serotonin activation with various intensity of physical and psychological stress in the rat brain , 1994, Pharmacology Biochemistry and Behavior.

[196]  G. Mcclearn,et al.  Alcohol acceptance, preference, and sensitivity in mice. I. Quantitative genetic analysis using BXD recombinant inbred strains. , 1994, Alcoholism, clinical and experimental research.

[197]  R Hen,et al.  Enhanced aggressive behavior in mice lacking 5-HT1B receptor. , 1994, Science.

[198]  C. Dourish,et al.  Behavioural and pharmacological characterisation of the elevated “zero-maze” as an animal model of anxiety , 1994, Psychopharmacology.

[199]  M. Owen,et al.  The genetic basis of complex human behaviors. , 1994, Science.

[200]  N. Copeland,et al.  Expression of the mouse corticotropin-releasing hormone gene in vivo and targeted inactivation in embryonic stem cells. , 1994, The Journal of clinical investigation.

[201]  G. Koob,et al.  Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[202]  A. S. Eison,et al.  Serotonergic mechanisms in anxiety , 1994, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[203]  R. Rodgers,et al.  Influence of social isolation, gender, strain, and prior novelty on plus-maze behaviour in mice , 1993, Physiology & Behavior.

[204]  S. Amara,et al.  Neurotransmitter transporters: three distinct gene families , 1993, Current Opinion in Neurobiology.

[205]  N. Barden,et al.  Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression. , 1992, Molecular pharmacology.

[206]  T. Johnson,et al.  Mapping quantitative trait loci for behavioral traits in the mouse , 1992, Behavior genetics.

[207]  J. Vaughan,et al.  Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice. , 1992, Endocrinology.

[208]  A. Lajtha,et al.  Motor activity and the mesotelencephalic dopamine function. I. High-resolution temporal and genetic analysis of open-field behavior , 1992, Behavioural Brain Research.

[209]  P. Costa,et al.  Normal Personality Assessment in Clinical Practice: The NEO Personality Inventory. , 1992 .

[210]  N. Barden,et al.  Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene , 1992, Nature.

[211]  K. Lesch.  5-HT1A receptor responsivity in anxiety disorders and depression , 1991, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[212]  D. Murphy,et al.  Serotonin-selective arylpiperazines with neuroendocrine, behavioral, temperature, and cardiovascular effects in humans. , 1991, Pharmacological reviews.

[213]  J. Delacour,et al.  Contribution of the Roman strains of rats to the elaboration of animal models of memory , 1991, Physiology & Behavior.

[214]  F. Brush.  Genetic determinants of individual differences in avoidance learning: Behavioral and endocrine characteristics , 1991, Experientia.

[215]  J. Delacour,et al.  Roman strains as a psychogenetic model for the study of working memory: Behavioral and biochemical data , 1991, Pharmacology Biochemistry and Behavior.

[216]  D. Martin,et al.  Regulatory properties of brain glutamate decarboxylase (GAD): the apoenzyme of GAD is present principally as the smaller of two molecular forms of GAD in brain , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[217]  D. Watson,et al.  Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications. , 1991, Journal of abnormal psychology.

[218]  M. Erlander,et al.  Two genes encode distinct glutamate decarboxylases , 1991, Neuron.

[219]  G. Kennett,et al.  Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists. , 1989, European journal of pharmacology.

[220]  S. Woods,et al.  Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks. , 1987, The American journal of psychiatry.

[221]  Cloninger Cr.  A systematic method for clinical description and classification of personality variants: A proposal. , 1987 .

[222]  Wim E Crusio,et al.  The genetic architecture of behavioural responses to novelty in mice , 1986, Heredity.

[223]  S. File,et al.  Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the rat , 1985, Journal of Neuroscience Methods.

[224]  J. Crawley.  Exploratory behavior models of anxiety in mice , 1985, Neuroscience & Biobehavioral Reviews.

[225]  D. Charney,et al.  Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. , 1984, Archives of general psychiatry.

[226]  D. Blizard,et al.  The Maudsley reactive and nonreactive strains: A North American perspective , 1981, Behavior genetics.

[227]  A. Guidotti,et al.  Benzodiazepines: a tool to explore the biochemical and neurophysiological basis of anxiety. , 1980, Federation proceedings.

[228]  P. C. Sakellaris,et al.  Genetic selection for avoidance behavior in the rat , 1979, Behavior genetics.

[229]  C Braestrup,et al.  Brain Specific Benzodiazepine Receptors , 1978, British Journal of Psychiatry.

[230]  P. L. Broadhurst.  The Maudsley Reactive and Nonreactive strains of rats: A survey , 1975, Behavior genetics.

[231]  G. Omenn.  Contributions to behavior-genetic analysis. The mouse as a prototype , 1971 .

[232]  N. Henderson,et al.  Prior treatment effects on open field behaviour of mice--a genetic analysis. , 1967, Animal behaviour.

[233]  G. Bignami,et al.  Selection for high rates and low rates of avoidance conditioning in the rat. , 1965, Animal behaviour.

[234]  K. Montgomery,et al.  The relation between fear induced by novel stimulation and exploratory drive. , 1955 .

[235]  C. S. Hall,et al.  Emotional behavior in the rat. III. The relationship between emotionality and ambulatory activity. , 1936 .

[236]  P. Skolnick,et al.  Differences in fear motivated behaviors among inbred mouse strains , 2005, Psychopharmacology.

[237]  R. Lister.  The use of a plus-maze to measure anxiety in the mouse , 2004, Psychopharmacology.

[238]  K. Lesch,et al.  Neuroticism and serotonin: A developmental genetic perspective. , 2003 .

[239]  M. Scheinin,et al.  Behavioral and neurochemical characterization of alpha(2A)-adrenergic receptor knockout mice. , 2002, Neuroscience.

[240]  F. Macciardi,et al.  Association between the dopamine transporter gene and posttraumatic stress disorder , 2002, Molecular Psychiatry.

[241]  K. Lesch.  Molecular foundation of anxiety disorders , 2001, Journal of Neural Transmission.

[242]  T. Brown,et al.  Reliability of DSM-IV anxiety and mood disorders: implications for the classification of emotional disorders. , 2001, Journal of abnormal psychology.

[243]  F. Holsboer,et al.  Regulation of the hypothalamic-pituitary-adrenocortical system in mice deficient for CRH receptors 1 and 2. , 2001, Endocrinology.

[244]  S. Gosling.  From mice to men: what can we learn about personality from animal research? , 2001, Psychological bulletin.

[245]  J. Crabbe,et al.  QTL Analysis and Genomewide Mutagenesis in Mice: Complementary Genetic Approaches to the Dissection of Complex Traits , 2001, Behavior genetics.

[246]  M. P. McDonald,et al.  The alpha(2a)-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety. , 2001, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[247]  W. Sieghart.  Unraveling the function of GABA(A) receptor subtypes. , 2000, Trends in pharmacological sciences.

[248]  K. J. Moore,et al.  Complex trait analysis in the mouse: The strengths, the limitations and the promise yet to come. , 2000, Annual review of genetics.

[249]  M. Picciotto.  Knock-out mouse models used to study neurobiological systems. , 1999, Critical reviews in neurobiology.

[250]  C. Nemeroff,et al.  The role of corticotropin-releasing factor in depression and anxiety disorders. , 1999, The Journal of endocrinology.

[251]  J. Crawley.  Chapter 4.6 Evaluating anxiety in rodents , 1999 .

[252]  J. Kennedy,et al.  Investigation of dopamine system genes in obsessive‐compulsive disorder , 1998, Psychiatric genetics.

[253]  J F Thayer,et al.  Autonomic balance revisited: panic anxiety and heart rate variability. , 1998, Journal of psychosomatic research.

[254]  M. Nöthen,et al.  Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease , 1998, Molecular Psychiatry.

[255]  B. Kobilka,et al.  Insights from in vivo modification of adrenergic receptor gene expression. , 1998, Annual review of pharmacology and toxicology.

[256]  A. Pickles,et al.  Genetic and Environmental Influences on Child Reports of Manifest Anxiety and Symptoms of Separation Anxiety and Overanxious Disorders: A Community-Based Twin Study , 1997, Behavior genetics.

[257]  M. Nöthen,et al.  Functional promoter polymorphism of the human serotonin transporter: lack of association with panic disorder. , 1997, Psychiatric genetics.

[258]  D. Pine,et al.  Panic disorder with smothering symptoms: Evidence for increased risk in first‐degree relatives , 1997, Depression and anxiety.

[259]  Michael Davis,et al.  Neurobiology of fear responses: the role of the amygdala. , 1997, The Journal of neuropsychiatry and clinical neurosciences.

[260]  G. Perrault,et al.  Genetic differences in the mouse defense test battery , 1997 .

[261]  E. Hollander,et al.  The neuroanatomy of 5-HT dysregulation and panic disorder. , 1997, The Journal of neuropsychiatry and clinical neurosciences.

[262]  S. Heinrichs,et al.  CRH overproduction in transgenic mice: behavioral and immune system modulation. , 1996, Annals of the New York Academy of Sciences.

[263]  S. Amara,et al.  Neurotransmitter transporters: recent progress. , 1993, Annual review of neuroscience.

[264]  F. Graeff.  Role of 5-HT in Defensive Behavior and Anxiety , 1993, Reviews in the neurosciences.

[265]  J. Pratt,et al.  The neuroanatomical basis of anxiety. , 1992, Pharmacology & therapeutics.

[266]  Michael Davis,et al.  The role of the amygdala in fear-potentiated startle: implications for animal models of anxiety. , 1992, Trends in pharmacological sciences.

[267]  H. Eysenck.  Dimensions of personality : 16, 5 or 3? ― Criteria for a taxonomic paradigm , 1991 .

[268]  P. Costa,et al.  Personality in adulthood , 1990 .

[269]  I. Törk.  30 – Raphe Nuclei and the Serotonergic System , 1990 .

[270]  C. R. Cloninger,et al.  A unified biosocial theory of personality and its role in the development of anxiety states: a reply to commentaries. , 1988, Psychiatric developments.

[271]  C. Robert Cloninger.  A systematic method for clinical description and classification of personality variants. A proposal. , 1987, Archives of general psychiatry.

[272]  Cloninger Cr.  Discussions arising from: Cloninger, CR. A. unified biosocial theory of personality and its role in the development of anxiety states. , 1987, Psychiatric developments.

[273]  C. Braestrup,et al.  Benzodiazepine receptor ligands with positive and negative efficacy. , 1983, Neuropharmacology.

[274]  J. Gray,et al.  A Critique of Eysenck’s Theory of Personality , 1981 .

[275]  K. Montgomery,et al.  The relation between fear induced by novel stimulation and exploratory behavior. , 1955, Journal of comparative and physiological psychology.

[276]  J. Macfarlane.  Personality: A Systematic, Theoretical and Factual Study. , 1952 .

[277]  R. Cattell.  Personality: A systematic theoretical and factual study, 1st ed. , 1950 .